Li Y, Chen S, Rao H, Cui S, Chen G
Adv Sci (Weinh). 2025; 12(7):e2414625.
PMID: 39836690
PMC: 11831481.
DOI: 10.1002/advs.202414625.
Hanson W, Romero Agosto G, Rouskin S
Viruses. 2024; 16(11).
PMID: 39599817
PMC: 11599142.
DOI: 10.3390/v16111702.
Liu F, Liu B, Xu S, Ni Y, Liu X
Endocr J. 2024; 72(1):53-67.
PMID: 39358210
PMC: 11778391.
DOI: 10.1507/endocrj.EJ24-0317.
Correia de Sousa M, Delangre E, Berthou F, El Harane S, Maeder C, Fournier M
JHEP Rep. 2024; 6(9):101126.
PMID: 39263327
PMC: 11388170.
DOI: 10.1016/j.jhepr.2024.101126.
Hussain M, Moglad E, Afzal M, Sharma S, Gupta G, Sivaprasad G
CNS Neurosci Ther. 2024; 30(5):e14763.
PMID: 38790149
PMC: 11126788.
DOI: 10.1111/cns.14763.
Meeting the Challenge of Controlling Viral Immunopathology.
Berber E, Mulik S, Rouse B
Int J Mol Sci. 2024; 25(7).
PMID: 38612744
PMC: 11011832.
DOI: 10.3390/ijms25073935.
Circulating afamin positively correlated with the miR-122 expression and type 2 diabetes mellitus-related phenotype according to the duration of diabetes.
Mokhtari Ardekani A, Kharazinejad E, Ghasemi E, Ghasemi H, Soltani R
Heliyon. 2024; 10(7):e28053.
PMID: 38560140
PMC: 10979149.
DOI: 10.1016/j.heliyon.2024.e28053.
Exploratory Analysis of MicroRNA Alterations in a Neurodevelopmental Mouse Model for Autism Spectrum Disorder and Schizophrenia.
Garcia-Cerro S, Gomez-Garrido A, Garcia G, Crespo-Facorro B, Brites D
Int J Mol Sci. 2024; 25(5).
PMID: 38474035
PMC: 10932205.
DOI: 10.3390/ijms25052786.
Therapeutic role of miR-19a/b protection from influenza virus infection in patients with coronary heart disease.
Xing Y, Chen L, Hu B, Li Y, Mai H, Li G
Mol Ther Nucleic Acids. 2024; 35(1):102149.
PMID: 38435118
PMC: 10907223.
DOI: 10.1016/j.omtn.2024.102149.
Role of microRNAs in Immune Regulation with Translational and Clinical Applications.
Gaal Z
Int J Mol Sci. 2024; 25(3).
PMID: 38339220
PMC: 10856342.
DOI: 10.3390/ijms25031942.
Trials and Tribulations of MicroRNA Therapeutics.
Seyhan A
Int J Mol Sci. 2024; 25(3).
PMID: 38338746
PMC: 10855871.
DOI: 10.3390/ijms25031469.
Serum MicroRNA profiles in chronic hepatitis C Egyptian patients before and after combined sofosbuvir and daclatasvir treatment.
Ezzat W, Amr K, Tawfeek S, Elbatae H, Bayomi E, Heiba A
BMC Infect Dis. 2024; 24(1):67.
PMID: 38195397
PMC: 10775543.
DOI: 10.1186/s12879-023-08016-2.
Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer.
Kamiya H, Komatsu S, Takashima Y, Ishida R, Arakawa H, Nishibeppu K
Br J Cancer. 2023; 130(4):671-681.
PMID: 38148376
PMC: 10876550.
DOI: 10.1038/s41416-023-02532-3.
MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets.
Kimura M, Kothari S, Gohir W, Camargo J, Husain S
Clin Microbiol Rev. 2023; 36(4):e0001523.
PMID: 37909789
PMC: 10732047.
DOI: 10.1128/cmr.00015-23.
MicroRNAs as Biomarkers and Therapeutic Targets for Acute Kidney Injury.
Tsuji K, Nakanoh H, Fukushima K, Kitamura S, Wada J
Diagnostics (Basel). 2023; 13(18).
PMID: 37761260
PMC: 10529274.
DOI: 10.3390/diagnostics13182893.
RNA-based medicine: from molecular mechanisms to therapy.
Sparmann A, Vogel J
EMBO J. 2023; 42(21):e114760.
PMID: 37728251
PMC: 10620767.
DOI: 10.15252/embj.2023114760.
Controlling viral inflammatory lesions by rebalancing immune response patterns.
Mulik S, Berber E, Sehrawat S, Rouse B
Front Immunol. 2023; 14:1257192.
PMID: 37671156
PMC: 10475736.
DOI: 10.3389/fimmu.2023.1257192.
Is there a potential of circulating miRNAs as biomarkers in rheumatic diseases?.
Prajzlerova K, Senolt L, Filkova M
Genes Dis. 2023; 10(4):1263-1278.
PMID: 37397550
PMC: 10311055.
DOI: 10.1016/j.gendis.2022.08.011.
Inhibition of miR-200b-3p confers broad-spectrum resistance to viral infection by targeting TBK1.
Fang A, Yuan Y, Sui B, Wang Z, Zhang Y, Zhou M
mBio. 2023; 14(4):e0086723.
PMID: 37222520
PMC: 10470528.
DOI: 10.1128/mbio.00867-23.
Plasma miR-1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer.
Takashima Y, Komatsu S, Ohashi T, Kiuchi J, Nishibeppu K, Kamiya H
Cancer Sci. 2023; 114(7):3027-3040.
PMID: 37190912
PMC: 10323105.
DOI: 10.1111/cas.15830.